Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.810
-0.040 (-2.16%)
Apr 29, 2026, 3:10 PM EDT - Market open
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $222 million as of April 29, 2026. Its market cap has increased by 346.68% in one year.
Market Cap
222.00M
Enterprise Value
179.32M
1-Year Change
346.68%
Ranking
Category
Stock Price
$1.81
Market Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $363.46M to $222.00M, a decrease of -38.92%. That is a compound annual growth rate of -6.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 228.13M | 11.18% |
| Dec 31, 2025 | 205.20M | 31.26% |
| Dec 31, 2024 | 156.32M | 117.39% |
| Dec 29, 2023 | 71.91M | -57.49% |
| Dec 30, 2022 | 169.15M | -38.80% |
| Dec 31, 2021 | 276.39M | 38.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adagene | 243.81M |
| Orchestra BioMed Holdings | 241.69M |
| Codexis | 238.08M |
| Fennec Pharmaceuticals | 235.81M |
| Nuvectis Pharma | 235.78M |
| Camp4 Therapeutics | 230.52M |
| Polaryx Therapeutics | 229.61M |
| Keros Therapeutics | 226.95M |